Antibodies: Difference between revisions

From Open Source Ecology
Jump to navigation Jump to search
No edit summary
Line 3: Line 3:


=Approaches=
=Approaches=
*GigaGen - [https://www.fiercebiotech.com/biotech/gigagen-jumps-into-covid-19-arena-polyclonal-antibodies]
*GigaGen - [https://www.fiercebiotech.com/biotech/gigagen-jumps-into-covid-19-arena-polyclonal-antibodies] - ''uses single-cell sequencing to “capture and recreate” whole libraries of antibodies from recovered COVID-19 patients. The company can then choose which of those antibodies to turn into recombinant polyclonal antibody treatments''


=Definitions=
=Definitions=
*Antigen. [https://www.google.com/search?q=example+of+an+antigen&oq=example+of+an+antigen&aqs=chrome..69i57j0l5.6058j1j7&client=ubuntu&sourceid=chrome&ie=UTF-8] - ex: a virus.
*Antigen. [https://www.google.com/search?q=example+of+an+antigen&oq=example+of+an+antigen&aqs=chrome..69i57j0l5.6058j1j7&client=ubuntu&sourceid=chrome&ie=UTF-8] - ex: a virus.
*Recombinant DNA - genetic engineering of DNA that does not yet exist in nature  - [https://en.wikipedia.org/wiki/Recombinant_DNA]
*Recombinant DNA - genetic engineering of DNA that does not yet exist in nature  - [https://en.wikipedia.org/wiki/Recombinant_DNA]

Revision as of 02:27, 6 April 2020

  • Antibodies are blood proteins that kill cellular intruders (disease) - [1]
  • How do you culture antibodies? Via hybridomas - [2]

Approaches

  • GigaGen - [3] - uses single-cell sequencing to “capture and recreate” whole libraries of antibodies from recovered COVID-19 patients. The company can then choose which of those antibodies to turn into recombinant polyclonal antibody treatments

Definitions

  • Antigen. [4] - ex: a virus.
  • Recombinant DNA - genetic engineering of DNA that does not yet exist in nature - [5]